Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer

[1]  J. Donovan,et al.  Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer , 2014, British Journal of Cancer.

[2]  T. Conroy,et al.  Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial. , 2014, The Lancet. Oncology.

[3]  M. Ychou,et al.  Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data. , 2013, European journal of cancer.

[4]  C. Hurt,et al.  Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial. , 2013, The Lancet. Oncology.

[5]  P. Kienle,et al.  Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus. , 2013, The Cochrane database of systematic reviews.

[6]  David Moher,et al.  Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. , 2013, JAMA.

[7]  E. Smets,et al.  Meta-analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery , 2013, Quality of Life Research.

[8]  E. Smets,et al.  Meta-analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery , 2013, Quality of Life Research.

[9]  M. Sprangers,et al.  Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer , 2013, Quality of Life Research.

[10]  P. Fayers,et al.  Patient-reported outcomes after hepatic resection of colorectal cancer metastases. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  N. Orsini,et al.  Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  C. Hurt,et al.  SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus , 2011, BMC Cancer.

[13]  M. Kranzfelder,et al.  Meta‐analysis of neoadjuvant treatment modalities and definitive non‐surgical therapy for oesophageal squamous cell cancer , 2011, The British journal of surgery.

[14]  J. Pignon,et al.  Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[16]  J. Blazeby,et al.  Health‐related quality of life after minimally invasive oesophagectomy , 2010, The British journal of surgery.

[17]  K. Ohtomo,et al.  A retrospective comparison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery for clinical stage II–III esophageal carcinoma , 2009, Journal of surgical oncology.

[18]  S. Kato,et al.  Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. , 2009, International journal of radiation oncology, biology, physics.

[19]  A. Finlay,et al.  The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results , 2008, The British journal of dermatology.

[20]  J. Blazeby,et al.  The Role of Health-Related Quality of Life Outcomes in Clinical Decision Making in Surgery for Esophageal Cancer: A Systematic Review , 2008, Annals of Surgical Oncology.

[21]  K. O'Byrne,et al.  Quality of life and survival in patients treated with radical chemoradiation alone for oesophageal cancer. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

[22]  D. Sugarbaker,et al.  Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  D. Alderson,et al.  Quality of life during potentially curative treatment for locally advanced oesophageal cancer , 2007, The British journal of surgery.

[24]  T. Conroy,et al.  Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Val Gebski,et al.  Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. , 2007, The Lancet. Oncology.

[26]  J. Moore,et al.  Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone , 2006, The British journal of surgery.

[27]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[28]  R. Malthaner,et al.  Preoperative chemotherapy for resectable thoracic esophageal cancer. , 2006, The Cochrane database of systematic reviews.

[29]  J. Donovan,et al.  Health‐related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma , 2005, Cancer.

[30]  P. Fayers,et al.  Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. , 2003, European journal of cancer.

[31]  D. Girling.  Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial , 2002, The Lancet.

[32]  R. Malthaner,et al.  Preoperative chemotherapy for resectable thoracic esophageal cancer. , 2015, The Cochrane database of systematic reviews.

[33]  R. Malthaner,et al.  WITHDRAWN. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. , 2010, The Cochrane database of systematic reviews.

[34]  Aller,et al.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. , 2002, The New England journal of medicine.

[35]  J. Farndon,et al.  Quality of life in patients with oesophageal cancer. , 2000, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[36]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[37]  D. Osoba,et al.  Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  Andrew Bottomley,et al.  EORTC QLQ-C30 Scoring Manual , 1995 .

[39]  A. Finlay,et al.  Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.

[40]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.